EUVIMEDEUVIMED entdecken
Editorial

Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials

Anju Nohria, Ann S LaCasce iD

Journal of Clinical Oncology · 01.08.2026 · 44 (22) · 2071-2074

DOI: 10.1200/jco-26-00383 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.08.2026. Verfasst von Anju Nohria und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Brigham and Women's Hospital, Boston, MA. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Cardiovascular Division, Brigham and Women's Hospital, Boston, MA.
  • Adult Medical Oncology, Dana Farber Cancer Institute, Boston, MA.

ORCID-Profile: Ann S LaCasce

Zitieren

APA

Nohria, A., & LaCasce, A. S. (2026). Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials. Journal of Clinical Oncology, 44(22), 2071-2074. https://doi.org/10.1200/jco-26-00383

Vancouver

Nohria A, LaCasce AS. Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials. Journal of Clinical Oncology. 2026;44(22):2071-2074. doi:10.1200/jco-26-00383

BibTeX
@article{Nohria2026,
  author = {Nohria, Anju and LaCasce, Ann S},
  title = {Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {22},
  pages = {2071--2074},
  doi = {10.1200/jco-26-00383}
}
Kostenlos starten →